Trials Sponsors Conditions Drugs Pricing

Conditions

Injection Site Haematoma Local Anesthetic Toxicity

Keywords

"SAPB""MRM""pain management"

Outcome Measures

Primary Outcomes (2)

the time of first rescue analgesic
the time taken by the patient to receive first dose of rescue analgesia, guided by the patients VAS score ( if the patients VAS score is 4 or more, the patient receives 50 mg of Pethidine).
it is measured for 24 hours after the end of surgery.
total dose of rescue analgesics
the total dose of Pethidine needed by each patient measured in mg.
it is measured for 24 hours after the end of surgery.

Secondary Outcomes (3)

patients satisfaction
24 hours after the end of surgery.
incidence of nausea and vomiting
24 hours after the end of surgery.
incidence of any block related complications.
24 hours after the end of surgery.

Study Arms (2)

Group A ( SAPB) group

EXPERIMENTAL

this group of patients receives serratus anterior plane block, just after induction of anesthesia.

Procedure: ultrasound guided serratus anterior plane block

Group B: control group

NO INTERVENTION

this group of patients does not receive any blockade, they receive conventional IV analgesics.

Interventions

ultrasound guided serratus anterior plane blockProcedure

the patients receive local anesthetic (20 ml of Bupivacaine 0.25 %), injected superficial to the serratus muscle under ultrasound guidance.

Group A ( SAPB) group

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age20 Years - 60 Years

Sexfemale

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

Females aged between 20-60 years old.
Preoperative physical status: ASA (American Society of Anesthesiology) I \& II.

Sponsors & Collaborators

Ain Shams University
Otherlead

Study Sites (1)

Ain Shams University Hospitals

Cairo, Abbasia, Egypt

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

Hala Gomaa Salama, Medical Doctorate
Anesthesia department, Ain Shams University, Cairo, Egypt.
STUDY DIRECTOR
Hanan Mahmoud Farag, Medical Doctorate
Anesthesia department, Ain Shams University, Cairo, Egypt.
STUDY DIRECTOR

Enrollment

40 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: DOUBLE
Who Masked: PARTICIPANT, INVESTIGATOR
Masking Details: double blind
Purpose: OTHER
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 26, 2021

First Posted

November 19, 2021

Study Start

March 10, 2020

Actual (reported)

U/S Guided SAPB Versus Conventional IV Analgesics in Postoperative Pain Management in MRM

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (3)

Study Arms (2)

Group A ( SAPB) group

Group B: control group

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (3)

Study Arms (2)

Group A ( SAPB) group

Group B: control group

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations